251 related articles for article (PubMed ID: 22574085)
1. Prognostic factors in laser treatment of upper urinary tract urothelial tumours.
Niţă G; Georgescu D; Mulţescu R; Draguţescu M; Mihai B; Geavlete B; Persu C; Geavlete P
J Med Life; 2012 Feb; 5(1):33-8. PubMed ID: 22574085
[TBL] [Abstract][Full Text] [Related]
2. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
3. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
[TBL] [Abstract][Full Text] [Related]
4. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma.
Cornu JN; Rouprêt M; Carpentier X; Geavlete B; de Medina SG; Cussenot O; Traxer O
World J Urol; 2010 Apr; 28(2):151-6. PubMed ID: 20044752
[TBL] [Abstract][Full Text] [Related]
5. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
7. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
[TBL] [Abstract][Full Text] [Related]
8. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
[TBL] [Abstract][Full Text] [Related]
9. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
10. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
11. [Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology].
Rouprêt M; Wallerand H; Traxer O; Roy C; Mazerolles C; Saint F; Quintens H; Amsellem-Ouazana D; Bernardini S; Guy L; Soulié M; Pfister C
Prog Urol; 2010 Apr; 20(4):260-71. PubMed ID: 20380988
[TBL] [Abstract][Full Text] [Related]
12. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
13. Nephroureterectomy for transitional cell carcinoma - the value of pre-operative histology.
Chitale S; Mbakada R; Irving S; Burgess N
Ann R Coll Surg Engl; 2008 Jan; 90(1):45-50. PubMed ID: 18201500
[TBL] [Abstract][Full Text] [Related]
14. [Endoscopic removal of papillary tumors of upper urinary tract].
Akopyan GN; Alyaev YG; Vinarov AZ; Rapoport LM; Gazimiev MA; Tsarichenko DG; Shpot EV; Sorokin NI; Dymov AM; Pshikhachev AM; Lekarev VY; Akopyan GS
Urologiia; 2016 Dec; (6):100-106. PubMed ID: 28248052
[TBL] [Abstract][Full Text] [Related]
15. Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and/or holmium-YAG laser ablation.
Tada Y; Yokomizo A; Koga H; Seki N; Kuroiwa K; Tatsugami K; Yamaguchi A; Naito S
BJU Int; 2010 Aug; 106(3):362-6. PubMed ID: 20201842
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.
Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR
BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024
[TBL] [Abstract][Full Text] [Related]
17. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
Luo HL; Kang CH; Chen YT; Chuang YC; Cheng YT; Lee WC; Chiang PH
Int J Urol; 2014 Apr; 21(4):366-9. PubMed ID: 24118071
[TBL] [Abstract][Full Text] [Related]
18. Long-term ureteroscopic management of upper tract urothelial carcinoma: 28-year single-centre experience.
Maruyama Y; Araki M; Wada K; Yoshinaga K; Mitsui Y; Sadahira T; Nishimura S; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Monga M; Nasu Y; Kumon H
Jpn J Clin Oncol; 2021 Jan; 51(1):130-137. PubMed ID: 32715306
[TBL] [Abstract][Full Text] [Related]
19. Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.
Boorjian S; Ng C; Munver R; Palese MA; Sosa RE; Vaughan ED; Del Pizzo JJ; Scherr DS
J Endourol; 2004 Nov; 18(9):912-6. PubMed ID: 15659932
[TBL] [Abstract][Full Text] [Related]
20. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
